tetano
Editor, Senior Moderator
Vet Res
. 2025 Jul 21;56(1):154.
doi: 10.1186/s13567-025-01590-0. Heterologous signal peptide grafting enhances the immune efficacy of Salmonella vectors delivering hemagglutinin against H7N9 avian influenza virus
Wangyangji Sun[SUP] 1 2 [/SUP], Rui Zhu[SUP] 1 2 [/SUP], Yu-An Li[SUP] 1 2 [/SUP], Zewei Li[SUP] 1 2 [/SUP], Yuanzhao Du[SUP] 3 [/SUP], Shifeng Wang[SUP] 4 [/SUP], Huoying Shi[SUP] 5 6 7 [/SUP]
Affiliations
Salmonella enterica serovar Typhimurium (S. Typhimurium) vectors, which induce broad cellular and humoral immune responses, are excellent candidates for delivering foreign antigens. However, S. Typhimurium strains display limitations, including low levels of antigen protein expression when delivering viral antigens. In this study, we found that replacing the hemagglutinin (HA) precursor sequence of H9N2 AIV (avian influenza virus) with that from H7N9 AIV significantly improved HA protein expression. Building on this, we combined the H9N2 HA leader sequence with a tissue plasminogen activator (tPA) signal peptide and delayed lysis Salmonella mRNA interferase regulation vector (SIRV) system previously developed by our team. This novel approach markedly enhanced the expression of viral antigens delivered by Salmonella vectors. Our results demonstrate that both the H9N2 HA leader sequence and the tissue plasminogen activator (tPA) signal peptide significantly increased H7N9 AIV HA protein expression and substantially improved the protective efficacy of the attenuated S. Typhimurium vector delivering the H7N9 HA protein vaccine against H7N9 AIV challenge. These findings offer valuable insights for developing more effective attenuated Salmonella-based recombinant H7N9 AIV vaccines and provide a valuable reference for vaccine strategies against other infectious diseases.
Keywords: Salmonella vector; H7N9 avian influenza virus; Influenza virus; tissue plasminogen activator signal sequence.
. 2025 Jul 21;56(1):154.
doi: 10.1186/s13567-025-01590-0. Heterologous signal peptide grafting enhances the immune efficacy of Salmonella vectors delivering hemagglutinin against H7N9 avian influenza virus
Wangyangji Sun[SUP] 1 2 [/SUP], Rui Zhu[SUP] 1 2 [/SUP], Yu-An Li[SUP] 1 2 [/SUP], Zewei Li[SUP] 1 2 [/SUP], Yuanzhao Du[SUP] 3 [/SUP], Shifeng Wang[SUP] 4 [/SUP], Huoying Shi[SUP] 5 6 7 [/SUP]
Affiliations
- PMID: 40691858
- DOI: 10.1186/s13567-025-01590-0
Salmonella enterica serovar Typhimurium (S. Typhimurium) vectors, which induce broad cellular and humoral immune responses, are excellent candidates for delivering foreign antigens. However, S. Typhimurium strains display limitations, including low levels of antigen protein expression when delivering viral antigens. In this study, we found that replacing the hemagglutinin (HA) precursor sequence of H9N2 AIV (avian influenza virus) with that from H7N9 AIV significantly improved HA protein expression. Building on this, we combined the H9N2 HA leader sequence with a tissue plasminogen activator (tPA) signal peptide and delayed lysis Salmonella mRNA interferase regulation vector (SIRV) system previously developed by our team. This novel approach markedly enhanced the expression of viral antigens delivered by Salmonella vectors. Our results demonstrate that both the H9N2 HA leader sequence and the tissue plasminogen activator (tPA) signal peptide significantly increased H7N9 AIV HA protein expression and substantially improved the protective efficacy of the attenuated S. Typhimurium vector delivering the H7N9 HA protein vaccine against H7N9 AIV challenge. These findings offer valuable insights for developing more effective attenuated Salmonella-based recombinant H7N9 AIV vaccines and provide a valuable reference for vaccine strategies against other infectious diseases.
Keywords: Salmonella vector; H7N9 avian influenza virus; Influenza virus; tissue plasminogen activator signal sequence.